Browsing: Pharma

In the latest update on the coronavirus and vaccine-related debate heating up at the FDA,…

As the battle for promotion between rivals Novo Nordisk and Eli Lilly intensifies, French regulators…

Biopharmaceutical leaders face unprecedented pressures in 2026. Explore trends in AI-powered drug discovery, biopharma manufacturing reshoring, hot clinical pipelines, and FDA approvals for actionable insights.

Axum Therapeutics, which just won FDA expansion for Overity for the treatment of Alzheimer’s disease…

Pfizer, which is on the verge of better-than-expected first-quarter results and continues to grapple with…

German company BioNTech is shedding much of its manufacturing footprint, potentially cutting 1,860 jobs in…

Novartis continues its multi-year review with new plans to close its production facility in Wehr,…

Kyverna Therapeutics is taking a historic first step in approving a CAR-T therapy for an…

Although largely in the background until recently, Prolific Machines’ optogenetic approach to biomanufacturing is about…

Sanofi is significantly increasing its artificial intelligence capabilities. The French pharmaceutical company will invest $294…